SRZN Stock Analysis: Buy, Sell, or Hold?
SRZN - Surrozen, Inc. Common
$23.99
0.49 (2.09%)
â˛
5d:
+0.13%
30d:
+13.37%
90d:
-11.44%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 14, 2026
0d
Get Alerted When SRZN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: SRZN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: SRZN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: SRZN is currently trading at $23.99, which is considered slightly high relative to its 30-day fair value range of $20.68 to $24.18.
Technical Outlook: Technically, SRZN is in a strong downtrend. Immediate support is located at $22.84, while resistance sits at $26.27.
Market Sentiment: SRZN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $43.00 (+79.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SRZN is in a strong downtrend. Immediate support is located at $22.84, while resistance sits at $26.27.
Market Sentiment: SRZN scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $43.00 (+79.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$20.68 -
$24.18
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.1%
All Signals
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 79.2% below Wall St target ($43.00)
- WARNING: Composite score 31/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$20.68 -
$24.18
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$22.84
Resistance Level
$26.27
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.24
Wall Street Target
$43.00
(+79.2%)
Revenue Growth (YoY)
408.6%
Earnings Growth (YoY)
-37.0%
Share & Embed Analysis
Last updated: August 23, 2026 7:45 PM ET
Data refreshes hourly during market hours. Next update: 8:45 PM
Data refreshes hourly during market hours. Next update: 8:45 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRZN showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Tcg Crossover Gp Ii, Llc
BUY
106658 shares
2026-03-24
Tcg Crossover Gp Ii, Llc
BUY
15223 shares
2026-03-23
Tcg Crossover Gp Ii, Llc
BUY
1190 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 66 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 41 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 41 HOLD |
|
VRTX
Vertex Pharmaceuticals IâĻ |
BUY
34 analysts |
$560 | 30 SELL |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 49 HOLD |
